|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/397 | |
| A61P 35/00 |
| (11) | Number of the document | 1830838 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05852783.9 |
| Date of filing the European patent application | 2005-12-02 | |
| (97) | Date of publication of the European application | 2007-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/043668 |
| Date | 2005-12-02 |
| (87) | Number | WO 2006/060676 |
| Date | 2006-06-08 |
| (30) | Number | Date | Country code |
| 633161 P | 2004-12-03 | US |
| (72) |
ANDERSON, Kenneth, C., US
CHAUHAN, Dharminder, US
PALLADINO,Michael A., US
|
| (73) |
Nereus Pharmaceuticals, Inc.,
10480 Wateridge Circle, San Diego, CA 92121,
US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US |
| (54) | COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASES |
| COMPOSITIONS AND METHODS FOR TREATING NEOPLASTIC DISEASES |